Quarterly report pursuant to Section 13 or 15(d)


3 Months Ended
Mar. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Summary of Condensed Financial Information Related to Unconsolidated Equity Method Joint Ventures
As of
March 31, 2022 December 31, 2021
$ 8,419  $ 7,983 
Real estate
7,992  7,989 
Other assets
12,078  3,903 
Total assets $ 28,489  $ 19,875 
Liabilities and equity:
Accounts payable and other liabilities $ 16,581  $ 7,899 
Equity of:
Meritage (1)
4,726  4,752 
Other 7,182  7,224 
Total liabilities and equity $ 28,489  $ 19,875 
  Three Months Ended March 31,
  2022 2021
Revenue $ 9,238  $ 8,995 
Costs and expenses (8,272) (8,125)
Net earnings of unconsolidated entities $ 966  $ 870 
Meritage’s share of pre-tax earnings (1) (2)
$ 984  $ 750 

(1)Balance represents Meritage’s interest, as reflected in the financial records of the respective joint ventures. This balance may differ from the balance reported in the accompanying unaudited consolidated financial statements due to the following reconciling items: (i) timing differences for revenue and distributions recognition, (ii) step-up basis and corresponding amortization, (iii) capitalization of interest on qualified assets, (iv) income deferrals as discussed in Note (2) below and (v) the cessation of allocation of losses from joint ventures in which we have previously written down our investment balance to zero and where we have no commitment to fund additional losses.
(2)Our share of pre-tax earnings from our mortgage joint venture is recorded in Earnings from financial services unconsolidated entities and other, net on the accompanying unaudited consolidated income statements. Our share of pre-tax earnings from all other joint ventures is recorded in Other (expense)/income, net on the accompanying unaudited consolidated income statements.